ArticleFrontiers in pharmacology2026

Distinct renal adverse event profiles among CDK4/6 inhibitors: a comparative pharmacovigilance analysis.

Suleyman Sami Guzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.